Neurology Search
Neurology Neurology

Conference Reports

Alzheimer's Association International Conference (AAIC) 2018
Chicago
22 July 2018 - 26 July 2018
Advances in Medicine 2017
19 May 2018 - 20 May 2018
2018 American Academy of Neurology Annual Meeting (AAN 2018)
Los Angeles, California, US
21 April 2018 - 27 April 2018
International Stroke Conference 2018 (ISC 2018)
Los Angeles, California, US
24 January 2018 - 26 January 2018
International Stroke Conference 2017 (ISC 2017)
Houston, Texas, US
22 February 2017 - 24 February 2017
49th Annual Meeting of the European Society for Paediatric Gastroenterology Hepatology and Nutrition (ESPGHAN) 2016
Athens, Greece
25 May 2016 - 28 May 2016
International Symposium on Cognitive and Developmental Neuroscience: From Molecular to Behaviour, Brain and Mind Institute, Chinese University of Hong Kong
12 November 2015 - 12 November 2015
Editor's Recommendations
Most Read Articles
Repeat doses of intrathecal nusinersen safe in infantile-onset SMA
Elvira Manzano, 29 May 2018
Repeat doses of the intrathecal antisense oligonucleotide nusinersen in children with infantile-onset spinal muscular atrophy (SMA) continue to demonstrate safety, according to  early data from the phase III SHINE extension study, bringing considerable hope to the SMA community.
Combo regimen confers PFS advantage for glioblastoma
Audrey Abella, 29 Aug 2018
The combination of the alkylating nitrosourea compound lomustine and the monoclonal antibody bevacizumab prolonged progression-free survival (PFS) in patients with progressive glioblastoma compared with either drug alone, a meta-analysis has shown.
Original New Drug Application Approvals by US FDA (16 - 31 August 2018)
31 Aug 2018
New drug applications approved by US FDA as of 16 - 31 August 2018 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.
Young people with ADHD more likely to have traumatic brain injury
29 Aug 2018
The risk of traumatic brain injury (TBI) is elevated in young people with attention-deficit/hyperactivity disorder (ADHD), though long-term ADHD medication can reduce this risk, a recent study has found.